QuantiFERON®-TB Gold assay for the diagnosis of latent tuberculosis infection

Expert Review of Molecular Diagnostics

Volumn 8, Issue 3, 2008, Pages 247-256

  Manuel, Oriol ^a   Kumar, Deepali ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

IFN release assay; Latent tuberculosis infection; Mycobacterium tuberculosis; Sensitivity; Specificity

Indexed keywords

GAMMA INTERFERON; BACTERIAL ANTIGEN;

BIOASSAY; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CONTROL; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; RISK BENEFIT ANALYSIS; SCREENING TEST; TUBERCULIN TEST; ANALYTICAL EQUIPMENT; BLOOD; CHEMISTRY; IMMUNOLOGY; MYCOBACTERIUM BOVIS; SENSITIVITY AND SPECIFICITY; TIME; TUBERCULOSIS;

ANTIGENS, BACTERIAL; HUMANS; INTERFERON TYPE II; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 44249103052     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.8.3.247     Document Type: Review

References (49)